(BCSF) Bain Capital Specialty - Overview

Sector: Financial Services | Industry: Asset Management | Exchange: NYSE (USA) | Market Cap: 804m USD | Total Return: -10.1% in 12m

Stock Direct Loans, Mezzanine Debt, Junior Securities, Secondary Purchases
Total Rating 26
Safety 49
Buy Signal -0.26
Asset Management +6.7
Asset Management & Custody Banks +6.7
Market Cap: 804m
Avg Trading Vol: 6.36M USD
ATR: 2.99%
Peers RS (IBD): 43.4
Risk 5d forecast
Volatility21.0%
Rel. Tail Risk3.89%
Reward TTM
Sharpe Ratio-0.59
Alpha-26.79
Character TTM
Beta0.608
Beta Downside1.239
Drawdowns 3y
Max DD25.77%
CAGR/Max DD0.58
EPS (Earnings per Share) EPS (Earnings per Share) of BCSF over the last years for every Quarter: "2021-03": 0.34, "2021-06": 0.34, "2021-09": 0.34, "2021-12": 0.34, "2022-03": 0.34, "2022-06": 0.41, "2022-09": 0.53, "2022-12": 0.37, "2023-03": 0.49, "2023-06": 0.6, "2023-09": 0.55, "2023-12": 0.54, "2024-03": 0.53, "2024-06": 0.51, "2024-09": 0.53, "2024-12": 0.52, "2025-03": 0.5, "2025-06": 0.37, "2025-09": 0.45, "2025-12": 0.46, "2026-03": 0,
EPS CAGR: -44.54%
EPS Trend: -41.4%
Last SUE: -4.00
Qual. Beats: 0
Revenue Revenue of BCSF over the last years for every Quarter: 2021-03: 43.993, 2021-06: 50.334, 2021-09: 40.365, 2021-12: 40.715, 2022-03: 46.309, 2022-06: 30.358, 2022-09: 28.679, 2022-12: 63.479, 2023-03: 51.844, 2023-06: 52.85, 2023-09: 58.447, 2023-12: 54.857, 2024-03: 57.594, 2024-06: 51.551, 2024-09: 55.735, 2024-12: 47.998, 2025-03: 51.986, 2025-06: 49.394, 2025-09: 42.674, 2025-12: 95.141, 2026-03: null,
Rev. CAGR: 21.17%
Rev. Trend: 48.1%
Last SUE: -1.30
Qual. Beats: 0
Description: BCSF Bain Capital Specialty

BCSF is a Business Development Company (BDC) that provides direct lending to middle-market companies. BDCs are regulated investment companies that invest in small and mid-sized businesses.

The company primarily focuses on senior secured investments, including first and second lien loans, unitranche debt, and mezzanine debt. These debt instruments are common in leveraged finance transactions.

BCSF targets companies with EBITDA between $10 million and $150 million. This segment often experiences higher demand for flexible financing solutions.

Further research on ValueRay can provide more in-depth financial analysis.

Headlines to Watch Out For
  • Middle-market loan demand impacts new investment volume
  • Interest rate fluctuations affect net investment income
  • Credit quality of portfolio companies drives loss provisions
  • Regulatory changes for BDCs influence operational costs
Piotroski VR‑10 (Strict) 3.0
Net Income: 98.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.05 > 1.0
NWC/Revenue: -164.1% < 20% (prev 44.23%; Δ -208.3% < -1%)
CFO/TA 0.03 > 3% & CFO 85.8m > Net Income 98.8m
Net Debt (1.41b) to EBITDA (183.1m): 7.71 < 3
Current Ratio: 0.35 > 1.5 & < 3
Outstanding Shares: last quarter (64.8m) vs 12m ago 0.40% < -2%
Gross Margin: 76.88% > 18% (prev 0.65%; Δ 7.62k% > 0.5%)
Asset Turnover: 9.04% > 50% (prev 8.09%; Δ 0.95% > 0%)
Interest Coverage Ratio: 1.52 > 6 (EBITDA TTM 183.1m / Interest Expense TTM 80.6m)
Altman Z'' -0.74
A: -0.15 (Total Current Assets 207.6m - Total Current Liabilities 600.0m) / Total Assets 2.66b
B: -0.02 (Retained Earnings -43.8m / Total Assets 2.66b)
C: 0.05 (EBIT TTM 122.3m / Avg Total Assets 2.65b)
D: -0.03 (Book Value of Equity -43.7m / Total Liabilities 1.55b)
Altman-Z'' Score: -0.74 = B
Beneish M
DSRI: 0.78 (Receivables 72.2m/82.7m, Revenue 239.2m/212.9m)
GMI: 0.84 (GM 76.88% / 64.92%)
AQI: none (AQ_t none / AQ_t-1 none)
SGI: 1.12 (Revenue 239.2m / 212.9m)
TATA: 0.00 (NI 98.8m - CFO 85.8m) / TA 2.66b)
Beneish M-Score: cannot calculate (missing components)
What is the price of BCSF shares? As of April 05, 2026, the stock is trading at USD 12.40 with a total of 379,253 shares traded.
Over the past week, the price has changed by +4.49%, over one month by +3.69%, over three months by -8.48% and over the past year by -10.12%.
Is BCSF a buy, sell or hold? Bain Capital Specialty has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold BCSF.
  • StrongBuy: 1
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the BCSF price?
Wallstreet Target Price 13.7 10.2%
Analysts Target Price 13.7 10.2%
BCSF Fundamental Data Overview as of 02 April 2026
P/E Trailing = 8.1046
P/E Forward = 10.1112
P/S = 2.9438
P/B = 0.7106
P/EG = 1.0474
Revenue TTM = 239.2m USD
EBIT TTM = 122.3m USD
EBITDA TTM = 183.1m USD
Long Term Debt = 870.8m USD (estimated: total debt 1.47b - short term 600.0m)
Short Term Debt = 600.0m USD (from shortTermDebt, last quarter)
Debt = 1.47b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.41b USD (from netDebt column, last quarter)
Enterprise Value = 2.14b USD (804.4m + Debt 1.47b - CCE 135.3m)
Interest Coverage Ratio = 1.52 (Ebit TTM 122.3m / Interest Expense TTM 80.6m)
EV/FCF = 24.94x (Enterprise Value 2.14b / FCF TTM 85.8m)
FCF Yield = 4.01% (FCF TTM 85.8m / Enterprise Value 2.14b)
FCF Margin = 35.87% (FCF TTM 85.8m / Revenue TTM 239.2m)
Net Margin = 41.29% (Net Income TTM 98.8m / Revenue TTM 239.2m)
Gross Margin = 76.88% ((Revenue TTM 239.2m - Cost of Revenue TTM 55.3m) / Revenue TTM)
Gross Margin QoQ = none% (prev 52.41%)
Tobins Q-Ratio = 0.80 (Enterprise Value 2.14b / Total Assets 2.66b)
Interest Expense / Debt = 1.33% (Interest Expense 19.6m / Debt 1.47b)
Taxrate = 2.80% (800k / 28.6m)
NOPAT = 118.9m (EBIT 122.3m * (1 - 2.80%))
Current Ratio = 0.35 (Total Current Assets 207.6m / Total Current Liabilities 600.0m)
Debt / Equity = 1.32 (Debt 1.47b / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = 7.71 (Net Debt 1.41b / EBITDA 183.1m)
Debt / FCF = 16.46 (Net Debt 1.41b / FCF TTM 85.8m)
Total Stockholder Equity = 1.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.73% (Net Income 98.8m / Total Assets 2.66b)
RoE = 8.72% (Net Income TTM 98.8m / Total Stockholder Equity 1.13b)
RoCE = 6.11% (EBIT 122.3m / Capital Employed (Equity 1.13b + L.T.Debt 870.8m))
RoIC = 4.52% (NOPAT 118.9m / Invested Capital 2.63b)
WACC = 3.71% (E(804.4m)/V(2.28b) * Re(8.12%) + D(1.47b)/V(2.28b) * Rd(1.33%) * (1-Tc(0.03)))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.20%
[DCF] Terminal Value 85.23% ; FCFF base≈96.5m ; Y1≈87.0m ; Y5≈74.9m
[DCF] Fair Price = 13.00 (EV 2.25b - Net Debt 1.41b = Equity 843.1m / Shares 64.9m; r=6.0% [WACC]; 5y FCF grow -12.27% → 3.0% )
EPS Correlation: -41.36 | EPS CAGR: -44.54% | SUE: -4.0 | # QB: 0
Revenue Correlation: 48.06 | Revenue CAGR: 21.17% | SUE: -1.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.41 | Chg7d=-0.003 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=1.61 | Chg7d=-0.047 | Chg30d=-0.047 | Revisions Net=-2 | Growth EPS=-14.5% | Growth Revenue=-6.8%
EPS next Year (2027-12-31): EPS=1.45 | Chg7d=-0.057 | Chg30d=-0.057 | Revisions Net=-2 | Growth EPS=-9.5% | Growth Revenue=-4.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.2% (Discount Rate 8.1% - Earnings Yield 12.3%)
[Growth] Growth Spread = -5.3% (Analyst -9.5% - Implied -4.2%)
External Resources
Dataroma Stockcircle